Stocks on Wall Street closed broadly lower Monday, giving back some of the big gains the market notched last week on hopes ...

Operational Growth: The company is seeing a resurgence in operational growth, driven by new product launches and a diversified pipeline. For example, the introduction of innovative treatments in ...

Pfizer laid off 100 employees in Bothell, Wash., according to a filing with the state Employment Security Department posted ...

Indian pharmaceutical stocks slipped sharply on Tuesday after US President Donald Trump vowed to slash drug prices ...

In Q2 2025, Pfizer reported notable revenues from key oncology drugs: The increasing demand for drugs like Padcev and the introduction of new therapies such as Elrexfio, which generated $85 million in ...

On August 25, the US president issued a sharp warning: drug prices in the US would be slashed by 1,400% to 1,500%, and ...

As GLP-1 adoption grows and new applications for the drugs come to light, experts say that could have sweeping impacts for ...

Even as Indian equities tripled investor wealth post-pandemic, several marquee stocks—from paints to pharma and banks—are ...

Pfizer stock is undervalued with strong non-COVID growth, robust Q2 2025 results, and strategic R&D pivots. See more on PFE ...

Companies have claimed improvements to yield, batch consistency and output while acknowledging the risks and challenges ...

Asian shares are lower following a broad decline on Wall Street that reversed some of the big gains from last week ...

Several bills in the California Legislature would regulate how companies use AI to make employment decisions such as compensation, hiring, firing, or promotions, but they may be in jeopardy ...